Dr. Kakra Hughes from Howard University discusses his ISET 2023 presentation on how race, ethnicity, and income is associated with a higher likelihood of amputation.
Dr. Kakra Hughes from Howard University discusses his ISET 2023 presentation on how race, ethnicity, and income is associated with a higher likelihood of amputation.
Vanderbilt University Medical Center, Nashville, Tennessee
Daniel Clair, MD
Vanderbilt Universi...
In this video from ISET 2023, Dr. Daniel Clair from Vanderbilt University Medical Center in Nashville, Tennessee, discusses his presentations on endograft durability and results of the PROMISE II trial.
In this video from ISET 2023, Dr. Daniel Clair from Vanderbilt University Medical Center in Nashville, Tennessee, discusses his presentations on endograft durability and results of the PROMISE II trial.
Presented by Ramon Varcoe, MBBS, MS, PhD, MMed (ClinEpi), Prince of Wales Hospital, Sydney, Australia
Written by Amanda Wright Harvey
Pres...
Dr. Ramon Varcoe presented results from SWING, a prospective, multicenter, single-arm, feasibility study that evaluated the safety and performance of the Sundance DCB in 35 patients at 8 test sites in Australia, New Zealand, and Europe.
Dr. Ramon Varcoe presented results from SWING, a prospective, multicenter, single-arm, feasibility study that evaluated the safety and performance of the Sundance DCB in 35 patients at 8 test sites in Australia, New Zealand, and Europe.
Presented by George Adams, MD MHS MBA FACC FSCAI, University of North Carolina REX Healthcare, Raleigh, North Carolina
Written by Amanda Wright Harvey
Pres...
In a session from Tuesday, George Adams, MD, MHS, MBA, FACC, FSCAI, from UNC REX Hospital in Raleigh, North Carolina, presented results from the LIBERTY 360 analysis on patients with chronic limb-threatening ischemia.
In a session from Tuesday, George Adams, MD, MHS, MBA, FACC, FSCAI, from UNC REX Hospital in Raleigh, North Carolina, presented results from the LIBERTY 360 analysis on patients with chronic limb-threatening ischemia.
Presented by Gunnar Tepe, MD, RoMed Hospital, Rosenheim, Germany
Written by Amanda Wright Harvey
Pres...
On Tuesday, Gunnar Tepe, MD, from RoMed Hospital in Rosenheim, Germany, provided attendees with an update on reintervention patterns in patients with in-stent restenosis, long lesions, and chronic total occlusions.
On Tuesday, Gunnar Tepe, MD, from RoMed Hospital in Rosenheim, Germany, provided attendees with an update on reintervention patterns in patients with in-stent restenosis, long lesions, and chronic total occlusions.
Presented by Venita Chandra, MD, Stanford University, Stanford, California
Presented by Venita Chandra, MD, Stan...
In a Tuesday ISET 2023 session, Venita Chandra, MD, from Stanford University in Stanford, California, presented study results on the use of paclitaxel with a drug-eluting stent (DES) and the importance of vessel sizing.
In a Tuesday ISET 2023 session, Venita Chandra, MD, from Stanford University in Stanford, California, presented study results on the use of paclitaxel with a drug-eluting stent (DES) and the importance of vessel sizing.
Presented by Peter A. Schneider, MD; Marianne Brodmann, MD; William Gray, MD; Kenneth Rosenfield, MD
Written by Amanda Wright Harvey
Pres...
In this session from Tuesday afternoon, Peter A. Schneider, MD, Marianne Brodmann, MD, William Gray, MD, and Kenneth Rosenfield, MD reported 24-month results from the TRANSCEND study, which compared the SurVeil drug-coated balloon (DCB) to...
In this session from Tuesday afternoon, Peter A. Schneider, MD, Marianne Brodmann, MD, William Gray, MD, and Kenneth Rosenfield, MD reported 24-month results from the TRANSCEND study, which compared the SurVeil drug-coated balloon (DCB) to...
Presented by Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM, Beth Israel Deaconess Medical Center, Boston, Massachusetts
Written by Amanda Wright Harvey
Pres...
In a Tuesday session at ISET, Dr. Eric Secemsky presented information on intravascular ultrasound imaging, which can significantly improve clinical outcomes in coronary interventions.
In a Tuesday session at ISET, Dr. Eric Secemsky presented information on intravascular ultrasound imaging, which can significantly improve clinical outcomes in coronary interventions.
Presented by Herbert D. Aronow, MD, MPH, FSVM, FACC, FSCAI, Henry Ford Health, Detroit, Michigan
Presented by Herbert D. Aronow, MD, M...
During a Monday morning session, Dr. Herbert Aronow, president of the Society for Vascular Medicine, discussed long-term goals following endovascular therapy for PAD.
During a Monday morning session, Dr. Herbert Aronow, president of the Society for Vascular Medicine, discussed long-term goals following endovascular therapy for PAD.
Presented by Jessica P. Simons, MD, MPH, DFSVS, UMass Chan Medical School, Worcester, Massachusetts
Presented by Jessica P. Simons, MD, M...
During Monday morning’s session on Essentials of Endovascular Therapy, Dr. Jessica P. Simons of UMass Chan Medical School presented information on evaluating and managing intermittent claudication and chronic limb-threatening ischemia (CLTI).
During Monday morning’s session on Essentials of Endovascular Therapy, Dr. Jessica P. Simons of UMass Chan Medical School presented information on evaluating and managing intermittent claudication and chronic limb-threatening ischemia (CLTI).
L. Raja, A. Valles
Purpose: Limb preservation through endovascular intervention of the right upper extremity with critical limb-threatening ischemia (CLTI), Rutherford class VI with gang...
J. Mustapha
Purpose: To evaluate the safety and efficacy of the Bare Temporary Spur Stent System for the treatment of infrapopliteal disease in subjects with critical limb ischemia (CLI)...
Dr. Marianne Brodmann discusses the results of the RANGER II SFA Randomized Trial in Women, Patients With Occlusions, and Severe Calcifications in this video from ISET 2022.
Dr. Marianne Brodmann discusses the results of the RANGER II SFA Randomized Trial in Women, Patients With Occlusions, and Severe Calcifications in this video from ISET 2022.
Purpose: To evaluate clinical outcomes in patients with critical limb ischemia (CLI) and long-segment (>38 mm) infrapopliteal lesions treated with everolimus-eluting coronary stents (E...
Purpose: Peripheral artery disease is a common condition that affects about 200 million people in the world. Treatment options include balloon angioplasty, bare-metal stents, drug-eluting...
Presented by Maureen Kohi, MD, FSIR, FCIRSE, FAHA, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Presented by Maureen Kohi, MD, FSIR, ...
During a Town Hall session at ISET 2022, Dr. Maureen Kohi of the University of North Carolina at Chapel Hill discussed the racial and ethnic disparities in patients with CLI and PAD.
During a Town Hall session at ISET 2022, Dr. Maureen Kohi of the University of North Carolina at Chapel Hill discussed the racial and ethnic disparities in patients with CLI and PAD.
Purpose: National benchmarking data on percentage case mix between academic and private interventional radiology (IR) practices helps better anticipate needs for practice building in diff...
Purpose: Radial arterial access has been shown to reduce vascular bleeding, complications, cost, length of stay, and mortality rate in patients undergoing intervention.
Purpose: Arterial calcification is common in peripheral arterial disease, often resulting in suboptimal clinical outcomes after angioplasty and stent placement. The use of intravascular l...
Purpose: Hypogastric artery pseudoaneurysm (HAP) has a rare incidence, and it is usually asymptomatic. It can present with neurologic symptoms such as paresthesia, sciatica, weakness of t...
Presented by Stephanie Silverman, American Diabetes Association
Presented by Stephanie Silverman, Ame...
During a Town Hall session at ISET 2022 focused on racial disparities in amputations, Stephanie Silverman, board member of the American Diabetes Association (ADA), spoke to attendees about the role that the ADA has taken in helping prevent...
During a Town Hall session at ISET 2022 focused on racial disparities in amputations, Stephanie Silverman, board member of the American Diabetes Association (ADA), spoke to attendees about the role that the ADA has taken in helping prevent...
Purpose: The purpose is to report the safety and efficacy of the Auryon Laser Atherectomy System (AngioDynamics) in a postmarket study treating infrainguinal lesions and occlusions.
...
Purpose: Peripheral artery disease is a growing pandemic, with a prevalence higher than ischemic heart disease and cancer combined. Critical limb ischemia, the deadliest form of the disea...
Purpose: Peripheral artery disease (PAD) continues to be underdiagnosed and thereby untreated early in its progression, leading to unnecessary health care costs and, more crucially, unnec...
Presented by Ramon L. Varcoe, MBBS, MS, PhD, MMed (ClinEpi)
Written by Debra L. Beck, MSc
Presen...
At ISET 2022, Dr. Ramon L. Varcoe presented the 5-year findings for the Absorb device and an update on resorbable drug-eluting scaffolds for BTK applications.
At ISET 2022, Dr. Ramon L. Varcoe presented the 5-year findings for the Absorb device and an update on resorbable drug-eluting scaffolds for BTK applications.
Christopher K. Zarins, MD, presented the 3-year findings from his recently published trial on the benefits of coronary computed-tomography derived FFRct in the evaluation of CLTI patients.
Christopher K. Zarins, MD, presented the 3-year findings from his recently published trial on the benefits of coronary computed-tomography derived FFRct in the evaluation of CLTI patients.
George Adams, MD, MHS, MBA, presented six-month data from the Tack Optimized Balloon Angioplasty II (TOBA II) Below the Knee (BTK) trial Friday morning at the International Symposium on Endovascular Therapy (ISET).
George Adams, MD, MHS, MBA, presented six-month data from the Tack Optimized Balloon Angioplasty II (TOBA II) Below the Knee (BTK) trial Friday morning at the International Symposium on Endovascular Therapy (ISET).
In an afternoon session at the International Symposium on Endovascular Therapy, presenters reviewed practical tips and techniques for treating patients with complex critical limb ischemia (CLI) and peripheral arterial disease (PAD).
In an afternoon session at the International Symposium on Endovascular Therapy, presenters reviewed practical tips and techniques for treating patients with complex critical limb ischemia (CLI) and peripheral arterial disease (PAD).
Hollywood, FL (January 24, 2020) – The Supera stent (Abbott Vascular) is a “fundamentally different design”, said Bret Wiechmann, MD, of Vascular & Interventional Physicians in Gainesville, Florida, in his Friday morning presentation on the...
Hollywood, FL (January 24, 2020) – The Supera stent (Abbott Vascular) is a “fundamentally different design”, said Bret Wiechmann, MD, of Vascular & Interventional Physicians in Gainesville, Florida, in his Friday morning presentation on the...
Michael R. Jaff, DO, Vice President of Clinical Affairs, Innovation, Technology and Peripheral Interventions at Boston Scientific, presented results from the COMPARE Pilot randomized clinical trial on Friday morning at the International...
Michael R. Jaff, DO, Vice President of Clinical Affairs, Innovation, Technology and Peripheral Interventions at Boston Scientific, presented results from the COMPARE Pilot randomized clinical trial on Friday morning at the International...
The study design of a recently published meta-analysis by Katasanos and colleagues is flawed, according to a critique presented by William Gray, MD, at the International Symposium on Endovascular Therapy (ISET).
The study design of a recently published meta-analysis by Katasanos and colleagues is flawed, according to a critique presented by William Gray, MD, at the International Symposium on Endovascular Therapy (ISET).
Hollywood, FL (January 23, 2020)- Results of the IN.PACT DEEP Global study show durable effectiveness and safety of the IN.PACT Admiral drug-coated balloon (DCB) (Medtronic) through 4 years, according to data presented by Gunnar Tepe, MD, at...
Hollywood, FL (January 23, 2020)- Results of the IN.PACT DEEP Global study show durable effectiveness and safety of the IN.PACT Admiral drug-coated balloon (DCB) (Medtronic) through 4 years, according to data presented by Gunnar Tepe, MD, at...
Hollywood, FL (January 23, 2020) – In the first and only head-to-head comparison of two paclitaxel-eluting stents used in peripheral intervention, no difference was seen for the primary endpoint of primary patency at 24 months. Clinical...
Hollywood, FL (January 23, 2020) – In the first and only head-to-head comparison of two paclitaxel-eluting stents used in peripheral intervention, no difference was seen for the primary endpoint of primary patency at 24 months. Clinical...
The Stellarex drug-coated balloon (DCB) (Philips) showed “excellent” safety and effectiveness in a real-world population of patients with complex peripheral artery disease (PAD).
The Stellarex drug-coated balloon (DCB) (Philips) showed “excellent” safety and effectiveness in a real-world population of patients with complex peripheral artery disease (PAD).
Findings from 7 different real-world data sources show no difference in survival following treatment with drug-coated and non-drug-coated devices, according to a presentation given today at the International Symposium on Endovascular Therapy...
Findings from 7 different real-world data sources show no difference in survival following treatment with drug-coated and non-drug-coated devices, according to a presentation given today at the International Symposium on Endovascular Therapy...
Hollywood, FL (January 23, 2020) – In a pooled analysis that included more than 1000 patients treated with the Lutonix 035 drug-coated balloon (DCB) (BD), no increase in mortality risk was seen compared to those treated with uncoated balloon...
Hollywood, FL (January 23, 2020) – In a pooled analysis that included more than 1000 patients treated with the Lutonix 035 drug-coated balloon (DCB) (BD), no increase in mortality risk was seen compared to those treated with uncoated balloon...
Vascular Disease Management spoke with Richard Neville, MD, Associate Director, INOVA Heart and Vascular Institute at INOVA Health System in Falls Church, Virginia. Dr. Neville discussed the importance of a multidisciplinary approach to...
Vascular Disease Management spoke with Richard Neville, MD, Associate Director, INOVA Heart and Vascular Institute at INOVA Health System in Falls Church, Virginia. Dr. Neville discussed the importance of a multidisciplinary approach to...
Fibromuscular dysplasia (FMD) is a non-atherosclerotic, non-inflammatory arterial disease that primarily affects women.1 It most commonly affects the renal, extra-cranial carotid, and vertebral arteries, but has been reported in almost every...
Fibromuscular dysplasia (FMD) is a non-atherosclerotic, non-inflammatory arterial disease that primarily affects women.1 It most commonly affects the renal, extra-cranial carotid, and vertebral arteries, but has been reported in almost every...
Severe peripheral arterial disease can contribute tremendous difficulty to cardiac procedures. Obtaining arterial access can be both technically difficult and a high risk for complications. We present a case of challenging access in patient...
Severe peripheral arterial disease can contribute tremendous difficulty to cardiac procedures. Obtaining arterial access can be both technically difficult and a high risk for complications. We present a case of challenging access in patient...
Interview with Erik G. Stilp, MD, FACC, RPVI, Ascension – Columbia St. Mary’s, Milwaukee, Wisconsin.
This article was originally published in Cath Lab Digest, Volume 27 - Issue 9 - September 2019.
Can you tell us about your practice?
Interview with Erik G. Stilp, MD, FACC, RPVI, Ascension – Columbia St. Mary’s, Milwaukee, Wisconsin.
This article was originally published in Cath Lab Digest, Volume 27 - Issue 9 - September 2019.
Can you tell us about your practice?
HOLLYWOOD, FL—Data presented for the first time in the US were featured during the 31st annual International Symposium on Endovascular Therapy (ISET). On Tuesday morning, Marianne Brodmann, MD, shared data from the Stellarex Vascular...
HOLLYWOOD, FL—Data presented for the first time in the US were featured during the 31st annual International Symposium on Endovascular Therapy (ISET). On Tuesday morning, Marianne Brodmann, MD, shared data from the Stellarex Vascular...
HOLLYWOOD, FL—First-time data from a first-in-human stem cell trial for hemodialysis arteriovenous fistula (AVF) were presented by Sanjay Misra, MD, at the 31st annual International Symposium on Endovascular Therapy (ISET). The study also won...
HOLLYWOOD, FL—First-time data from a first-in-human stem cell trial for hemodialysis arteriovenous fistula (AVF) were presented by Sanjay Misra, MD, at the 31st annual International Symposium on Endovascular Therapy (ISET). The study also won...
Live cases from Miami Cardiac and Vascular Institute as well as Houston Methodist were highlighted for audience members and a panel of experts in a session moderated by Chris Metzger, MD.
Live cases from Miami Cardiac and Vascular Institute as well as Houston Methodist were highlighted for audience members and a panel of experts in a session moderated by Chris Metzger, MD.
The ISET 2019 Townhall on paclitaxel addressed the controversy surrounding a recent meta-analysis by Katsanos and colleagues that has potentially significant implications for changing practice in the field.
The ISET 2019 Townhall on paclitaxel addressed the controversy surrounding a recent meta-analysis by Katsanos and colleagues that has potentially significant implications for changing practice in the field.
The vascular physical examination is key to diagnosis and care. At ISET 2019, a patient volunteer from Miami Cardiac and Vascular underwent a live vascular examination from Michael Jaff, DO, as panelists offered their comments.
The vascular physical examination is key to diagnosis and care. At ISET 2019, a patient volunteer from Miami Cardiac and Vascular underwent a live vascular examination from Michael Jaff, DO, as panelists offered their comments.
HOLLYWOOD, FL—Rapid advances in endovascular therapy mean that a wealth of research is undertaken each year with the goal of improving patient outcomes, including more than 140 posters and abstracts that are being presented as part of ISET...
HOLLYWOOD, FL—Rapid advances in endovascular therapy mean that a wealth of research is undertaken each year with the goal of improving patient outcomes, including more than 140 posters and abstracts that are being presented as part of ISET...
The Townhall session will delve into the details of the study, draw on the collective experience of experts, and provide practitioners with a consensus moving forward.
The Townhall session will delve into the details of the study, draw on the collective experience of experts, and provide practitioners with a consensus moving forward.
In this Q&A, James Benenati, MD, highlights key parts of the non-invasive vascular diagnosis symposium, including interactive polling and challenges. Attendees will learn diagnosis and interpretation of testing done in the carotid...
In this Q&A, James Benenati, MD, highlights key parts of the non-invasive vascular diagnosis symposium, including interactive polling and challenges. Attendees will learn diagnosis and interpretation of testing done in the carotid...
ISET 2019 begins with the Endovascular Essentials symposium on Sunday, January 27th. The symposium includes an interactive case-based session, a live vascular physical exam, and a review of the latest clinical trial data.
ISET 2019 begins with the Endovascular Essentials symposium on Sunday, January 27th. The symposium includes an interactive case-based session, a live vascular physical exam, and a review of the latest clinical trial data.
ISET 2019 begins with the...
01/23/2019
Vascular Disease Management
CLI/PAD
Advertisement
About
For over 30 years, ISET has served as the premier arena for pioneering and practical endovascular education. Join leaders in the fields of interventional radiology, interventional cardiology, vascular surgery, and more as they come together to explore groundbreaking techniques and technologies while exchanging discussion and debate that ultimately drive patient care forward. More about ISET
